Roivant Sciences Ltd. (ROIV)

Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,238	2,715	6,495	1,677	2,060	2,055
Short-Term Investments	3,265	2,171	-	-	-	-
Cash & Short-Term Investments	4,503	4,887	6,495	1,677	2,060	2,055
Cash Growth	-20.70%	-24.76%	287.34%	-18.62%	0.26%	-5.87%
Accounts Receivable	-	-	-	30.38	3.88	-
Other Receivables	-	-	-	7.27	2.85	-
Receivables	-	-	-	37.64	6.73	-
Inventory	-	-	-	2.76	-	-
Prepaid Expenses	-	-	-	60.83	53.37	-
Restricted Cash	2.26	2.36	3.07	5.01	3.9	77.7
Other Current Assets	110.34	110.82	233.81	15.53	22.12	54.25
Total Current Assets	4,616	5,000	6,732	1,799	2,147	2,187
Property, Plant & Equipment	101.94	101.08	59.32	92.34	86.95	77.03
Long-Term Investments	283.81	302.94	247.75	304.32	325.83	289.54
Other Intangible Assets	-	-	-	144.88	-	-
Other Long-Term Assets	31.09	32.86	183.58	49.48	25.82	36.13
Total Assets	5,033	5,437	7,222	2,390	2,585	2,590
Accounts Payable	11.55	23.69	14.03	37.83	34.58	20.55
Accrued Expenses	88.73	114.29	119.42	167.13	127.53	76.94
Current Portion of Long-Term Debt	-	-	-	40.72	-	-
Current Portion of Leases	9.4	9.84	8.97	11.69	11.4	12.31
Current Income Taxes Payable	-	0.42	9.77	0.54	0.71	-
Current Unearned Revenue	-	1.17	4.17	12.44	10.15	5.92
Other Current Liabilities	4.19	-	110.41	2.09	-	103.24
Total Current Liabilities	113.87	149.41	266.76	272.45	184.37	218.96
Long-Term Debt	-	-	-	375.52	210.03	170.28
Long-Term Leases	90.29	90.33	45.02	53.48	62.47	62.38
Other Long-Term Liabilities	12.54	10	462.18	80.58	66.84	76.06
Total Liabilities	216.7	249.74	773.95	782.02	523.7	527.69
Additional Paid-In Capital	4,644	4,562	5,396	4,933	4,422	3,815
Retained Earnings	-315.59	116.06	576.17	-3,773	-2,764	-1,918
Comprehensive Income & Other	17.14	9.44	-4.08	-2.62	-0.95	-98.56
Total Common Equity	4,346	4,688	5,969	1,158	1,657	1,798
Minority Interest	470.27	499.59	479.95	449.82	404.49	264.22
Shareholders' Equity	4,816	5,187	6,449	1,608	2,061	2,062
Total Liabilities & Equity	5,033	5,437	7,222	2,390	2,585	2,590
Total Debt	99.69	100.17	53.99	481.4	283.89	244.98
Net Cash (Debt)	4,403	4,787	6,441	1,195	1,777	1,810
Net Cash Growth	-16.91%	-25.68%	438.81%	-32.71%	-1.85%	-9.60%
Net Cash Per Share	6.19	6.60	7.75	1.68	2.65	2.87
Filing Date Shares Outstanding	682.88	679.81	738.72	766.81	700.77	222.67
Total Common Shares Outstanding	682.23	695.94	806.68	760.14	694.98	222.67
Working Capital	4,502	4,851	6,465	1,526	1,962	1,968
Book Value Per Share	6.37	6.74	7.40	1.52	2.38	8.07
Tangible Book Value	4,346	4,688	5,969	1,013	1,657	1,798
Tangible Book Value Per Share	6.37	6.74	7.40	1.33	2.38	8.07

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q